SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092288
Filing Date
2024-08-07
Accepted
2024-08-07 08:05:34
Documents
112
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-20240630.htm   iXBRL 10-Q 3186201
2 EX-31.1 mnkd-ex31_1.htm EX-31.1 14057
3 EX-31.2 mnkd-ex31_2.htm EX-31.2 14056
4 EX-32.1 mnkd-ex32_1.htm EX-32.1 9689
5 EX-32.2 mnkd-ex32_2.htm EX-32.2 9701
  Complete submission text file 0000950170-24-092288.txt   15441916

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20240630.xsd EX-101.SCH 2507886
115 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20240630_htm.xml XML 2856941
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 241181526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)